This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Liji Zhu - Innovator in NRIP1 Regulation
Introduction
Liji Zhu is a notable inventor based in Oakland Gardens, NY (US). She has made significant contributions to the field of biotechnology, particularly in the regulation of apolipoprotein A1. Her work focuses on innovative methods for identifying inhibitors of NRIP1, which have implications for treating various disorders.
Latest Patents
Liji Zhu holds a patent for her invention titled "NRIP1 regulation of apolipoprotein A1." This patent provides methods for identifying inhibitors of NRIP1 and outlines the use of these inhibitors in treating NRIP1-mediated disorders. The invention represents a crucial advancement in therapeutic strategies.
Career Highlights
Liji Zhu is currently employed at Schering Corporation, where she continues to develop her research and innovations. Her work at the company has allowed her to explore the potential of NRIP1 inhibitors in clinical applications.
Collaborations
Throughout her career, Liji has collaborated with esteemed colleagues, including Xiaorui Yao and Scott W. Altmann. These partnerships have enriched her research and contributed to the advancement of her projects.
Conclusion
Liji Zhu's innovative work in the regulation of apolipoprotein A1 and her patent on NRIP1 inhibitors highlight her significant contributions to biotechnology. Her ongoing research at Schering Corporation continues to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile